Aquatic Capital Management’s Integra LifeSciences IART Stock Holding History

Aquatic Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,172	Closed	-$299K	–	1428
2024 Q4	$299K	Buy	+13,172	New	+$288K	0.01%	847
2024 Q2	–	Sell	-49,700	Closed	-$1.76M	–	1398
2024 Q1	$1.76M	Buy	49,700 +36,600	+279%	+$1.46M	0.06%	271
2023 Q4	$571K	Buy	+13,100	New	+$516K	0.01%	603
2022 Q4	–	Sell	-11,500	Closed	-$487K	–	1574
2022 Q3	$487K	Buy	11,500 +7,700	+203%	+$395K	0.05%	408
2022 Q2	$205K	Buy	3,800 +3,400	+850%	+$204K	0.07%	330
2022 Q1	$26K	Sell	400 -600	-60%	-$39.5K	0.04%	426
2021 Q4	$67K	Buy	+1,000	New	+$67.7K	0.13%	224

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aquatic Capital Management's IART Position: Q1 2025 in Review

Aquatic Capital Management sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 13,172 shares — an estimated $299K sold.

Aquatic Capital Management first reported a position in IART in Q4 2021 and held it in 7 quarters. The position peaked at $1.76M in Q1 2024. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

Aquatic Capital Management reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
Aquatic Capital Management sold 13,172 Integra LifeSciences shares in Q1 2025, an estimated $299K.
Aquatic Capital Management first reported a position in Integra LifeSciences in Q4 2021 and held it in 7 quarters.
Aquatic Capital Management's Integra LifeSciences position peaked at $1.76M in Q1 2024.
219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.